Not applicableStudy completedNCT05216588
What this trial is testing
Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies With Early Access Authorization in Immunocompromised Patients. A Prospective Cohort.
Who this might be right for
COVID-19Immunocompromised Host
ANRS, Emerging Infectious Diseases 149